Description
Dextran Sulfate Sodium Salt (DSS) MW:36000~50000 | 60316ES80| Gentaur Distribution US, UK & Europe
Dextran sulfate sodium salt (DSS) is a polyanionic derivative of dextran produced by the esterification of Dextran with chlorosulphonic acid. The sulfur content is approximately 17% which corresponds to an average of 1.9 sulfate groups per glucosyl residue of the dextran molecule. DSS has several characteristics: 1) polyanionic complex, soluble in water, forming a colorless aqueous solution; 2) high purity and good stability; 3) can be degraded naturally. Inflammatory bowel disease (IBD) is a chronic, relapsing gastrointestinal infection that increases the risk of intestinal tumors, mainly including UC and Crohn disease (CD) . In 1988, after the hamster ulcerative colitis model was first prepared by using DSS, a large number of studies have proved that the DSS colitis model is similar to human ulcerative colitis. The histological features, clinical manifestations, disease site, and cytokine proliferation of the DSS colitis model are very similar to human ulcerative colitis (UC) . The modeling conditions and operation methods of this model are simple, the expenditure is very cheap, the repeatability is good, and it is easy to master and popularize. The DSS concentration and dosing time can be adjusted according to the experimental purpose to establish acute, chronic, and acute-chronic alternation models.
Product Category: Biochemical reagents.
Shipping Conditions: Room temperature/ambient.
Format: Powder.
Product Color: White
